Related Experiment Video

Updated: Oct 9, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides

M Nakazawa, S Kodama, T Matsuo

    Brain & Development
    |January 1, 1983
    PubMed

    Insights

    A ketogenic diet, rich in medium-chain triglycerides (MCT), enhanced anticonvulsive effects in mice. This diet increased brain adenosine triphosphate (ATP) levels, suggesting improved neuronal stability and potential for epilepsy management.

    Area of Science:

    • Neuroscience
    • Metabolic Disorders
    • Dietary Interventions

    Background:

    • The ketogenic diet is a high-fat, low-carbohydrate diet known for its anticonvulsant properties.
    • Medium-chain triglycerides (MCTs) are efficiently metabolized into ketones, which may enhance the diet's therapeutic effects.
    • Understanding the neurochemical mechanisms underlying the ketogenic diet's efficacy is crucial for its clinical application.

    Purpose of the Study:

    • To investigate the anticonvulsant effects of a ketogenic diet supplemented with MCTs in a mouse model.
    • To determine the impact of chronic ketosis on brain adenosine triphosphate (ATP) levels.
    • To explore the relationship between ATP levels and neuronal stability.

    Main Methods:

    • Mice were divided into three groups: control (standard diet), fasted (2 days), and ketotic (2 days fasting followed by 2 weeks ketogenic diet).
    • Maximal electroconvulsive threshold (MECT) was assessed using electroconvulsive shocking.
    • Adenosine nucleotide levels, specifically ATP, were measured in brain tissue.

    Main Results:

    • The ketotic group exhibited a significantly higher MECT compared to the fasted group (p < 0.001).
    • The fasted group showed a significantly higher MECT than the control group (p < 0.05).
    • Brain ATP content was significantly elevated in the ketotic group versus the control group (p < 0.01).

    Conclusions:

    • Chronic ketosis induced by a ketogenic diet increases brain ATP levels.
    • Elevated ATP levels likely contribute to enhanced neuronal stability and anticonvulsant effects.
    • The ketogenic diet, particularly with MCTs, shows promise for managing conditions characterized by neuronal hyperexcitability.

    More Related Videos

    Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins09:07

    Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

    Published on: August 15, 2017

    Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats08:47

    Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

    Published on: November 8, 2018

    Related Concept Videos

    Epilepsy and Seizures: Overview01:24

    Epilepsy and Seizures: Overview

    Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
    Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
    Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

    Antiepileptic Drugs: GABAergic Pathway Potentiators

    γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
    The key GABA pathway potentiators used in epilepsy management are as follows.
    Benzodiazepines are a well-known class of drugs used for their...
    Antiepileptic Drugs: Glutamate Antagonists01:14

    Antiepileptic Drugs: Glutamate Antagonists

    Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

    Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
    SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
    Antiepileptic Drugs: Potassium Channel Activators01:20

    Antiepileptic Drugs: Potassium Channel Activators

    Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
    Ezogabine has gained approval as an adjunctive treatment...
    Electroconvulsive Therapy01:30

    Electroconvulsive Therapy

    Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...